Toronto, Ontario--(May 6, 2021) - ScreenPro Security Inc. (CSE: SCRN) ("ScreenPro" or the "Company") is pleased to announce that the Company launched its medical app device, GoStop, with its film and television clients. ScreenPro has successfully integrated GoStop with its laboratory reporting systems.
GoStop is a COVID-19 digital passport developed with a privacy preserving approach that will enable people to use the alerting software and downloadable app with authentication certificates. COVID-19 tests uploaded to the app, with either a negative or positive test result, trigger an instant notification to individuals in the test group. In the case of a positive result, the app advises isolation for the subject and quarantine of their contacts.
When managing groups in the hundreds per film set over multiple locations, it is essential to have a patient centric reporting platform that can effectively announce who is clear and who is not clear to work in the shortest time frame possible. This type of efficiency was requested by the Company's clients who require individual reporting for each of their team members. Production employees and or film technicians, who register with the app and have their entire testing history recorded within the app with reminders to retest. This improves scheduling and reduces the workload on the covid medical team on set. If there is a positive test for COVID-19, the medical staff on set are notified and recommend immediate isolation. The app can also be used to book and record vaccinations for the virus and can be used as a vaccine passport as well. The company has applied to have the app registered for Android on the Google Play Store.
John McMullen CEO of ScreenPro, stated, "We are pleased to announce the successful blending of GoStop into ScreenPro's mobile passport to deliver reports directly from our labs to the client. This offering to our film and television clients offers a new level of efficiency and service to the patients. To offer this functionality, with efficient reporting gives the confidence that everyone on set is cleared so they can get back to work."
ScreenPro is a medical and technology services company that provides turnkey COVID-19 screening solutions to the public and private sector including PCR testing added with the GoStop, for their testing and vaccine passport app. ScreenPro has unique access to multiple manufacturers of high quality test kits and strategic laboratory partnerships with in Toronto and Vancouver. This testing platform allows ScreenPro to be a nationwide provider of full-service testing solutions across Canada. For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact: John McMullen Email: firstname.lastname@example.org
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.